Other
Toothache
20
Pipeline Programs↗
0
Active Trials↗
11
Companies Involved↗
Toothache is an emerging landscape with 20 programs across 11 companies. The most active players are Daewon Pharmaceutical Co., Ltd., Haisco Pharmaceutical Group Co., Ltd., Kenvue Brands. 13 therapies are approved with 4 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 1
No programs
Phase 34
Analysis
Trial Status
6
clinical trials
Completed5 · 83%
Terminated1 · 17%
Clinical Trials
Trial Activity
6 trials
The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache
Completed·—·Phase 4·NCT00574015·18 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)